Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up

Gynecologic Oncology

Volumn 127, Issue 3, 2012, Pages 502-505

  Fagotti, Anna ^a   Costantini, Barbara ^a   Petrillo, Marco ^a   Vizzielli, Giuseppe ^a   Fanfani, Francesco ^a   Margariti, Pasquale Alessandro ^a   Turco, Luigi Carlo ^a   Piovano, Elisa ^a,b   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Case control; HIPEC; Ovarian cancer; Platinum sensitive; Recurrence

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; OXALIPLATIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC INTRAPERITONEAL INTRAOPERATIVE CHEMOTHERAPY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PLATINUM; SURVIVAL ANALYSIS;

EID: 84868592353     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.09.020     Document Type: Article

References (20)

1. M.M. Leitao Jr., and D.S. Chi Surgical management of recurrent ovarian cancer Semin Oncol 36 2009 106 111
2. D.K. Armstrong, B. Bundy, and L. Wenzel Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 2006 43
3. T.C. Chua, G. Robertson, W. Liauw, R. Farrell, T.D. Yan, and D.L. Morris Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in EOC peritoneal carcinomatosis: systematic review of current results J Cancer Res Clin Oncol 135 2009 1637 1645
4. M. Deraco, D. Baratti, and B. Laterza Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer Eur J Surg Oncol 37 2011 4 9
5. P.A. Cascales, J. Gil, P.J. Galindo, F. Machado, I.M. Frutos, and P.P. Paricio Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma Eur J Obstet Gynecol Reprod Biol 158 2011 361 362
6. N. Golse, N. Bakrin, and G. Passot Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results J Surg Oncol 106 2 2012 197 203
7. A. Fagotti, I. Paris, and F. Grimolizzi Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study Gynecol Oncol 113 2009 335 340
8. A. Fagotti, B. Costantini, and G. Vizzielli HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome Gynecol Oncol 122 2011 221 225
9. G. Ferrandina, F. Legge, V. Salutari, A. Paglia, A. Testa, and G. Scambia Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations Eur J Cancer 42 2006 2296 2302
10. M.M. Oken, R.H. Creech, and D.C. Tormey Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655
11. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
12. A. Fagotti, F. Fanfani, and C. Rossitto A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy Oncology 75 2008 152 158
13. P.H. Sugarbaker Management of peritoneal surface malignancy using intraperitoneale chemotherapy and cytoreductive surgery. A manual for physicians and nurses 3rd edn 1998 The Ludann Company Grand Rapids, MI
14. E. Kaplan, and P. Meyer Non parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
15. IeM Shih, and R.J. Kurman Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis Am J Pathol 164 2004 1511 1518
16. J.A. Ledermann, and F.A. Raja Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer Eur J Cancer 47 Suppl. 3 2011 S104 S115
17. M. Markman, J. Markman, and K. Webster Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design J Clin Oncol 22 2004 3120 3125
18. R.E. Bristow, I. Puri, and D.S. Chi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis Gynecol Oncol 112 1 Jan 2009 265 274
19. A. Macrì, E. Saladino, and G. Trimarchi Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in elderly patients In Vivo 25 2011 687 690
20. H. Mueller, M. Hahn, and J. Simsa Cytoreductive surgery in the elderly patients - is it feasible? Hepatogastroenterology 55 2008 2005 2011